Scientists gather for research talks

01 March 2013

A wide range of QEHB’s healthcare scientists gathered for an event designed to encourage and discuss their contributions to research and to share experiences generally.

The event, organised by Director of Medical Physics Professor Stuart Green, involved scientists from a wide range of disciplines within the Trust.

Prof Green spoke about the need for scientists to be engaged with clinicians in the development and execution of clinical trials

“We are coming together more as healthcare scientists, putting together a network which can encourage our involvement in research and learn from each other on important issues such as training.”

Prof Stuart Green

Prof Stuart Green

The theme was echoed by consultant clinical scientist Dr Huw Cooper, who works alongside Prof Green as one of the Trust’s two scientific leads: “It’s great to see so many scientists coming together and I hope it’s the first of many such events.”

The event featured presentations from the Trust’s Deputy Director of Delivery Hilary Fanning, who gave an outline of the structures of health research across the West Midlands.

She was followed by Dr Sue Avery, the Regional Director of Healthcare Scientists for NHS Midlands, who provided a national perspective on role of scientists in clinical research and encouraged the audience to engage externally to promote their subject.

Several scientists from the Trust then provided brief overviews of the role of science in audiology, nuclear medicine, sleep and lung function, radiotherapy, medical illustration, neurophysiology, medical engineering and cellular pathology.

Other presentations looked at the scientific underpinnings of maxillofacial prosthetics, biochemistry and radiotherapy, followed by a session on talks on training within medical physics, neurophysiology and audiology.

Prof Green said afterwards that he was encouraged to see the level of interest from his fellow scientists: “Scientists have a very important role to play in research. As Sue Avery pointed out, around 80% of clinical decisions are directly influenced by scientific, and that’s a huge role.

“The input of scientists in developing new treatments is extremely important and the good attendance at this event shows we’re working well within our different disciplines and across specialties.